(Max Delbrück Center for Molecular Medicine in the Helmholtz Association) An international research team has succeeded in stopping the growth of malignant melanoma by reactivating a protective mechanism that prevents tumor cells from dividing. Show More Summary
(UNC Lineberger Comprehensive Cancer Center) In JCI Insight, UNC Lineberger's Stergios Moschos, MD, and colleagues published the results of a phase I, multi-institution clinical trial for an investigational treatment for melanoma and other cancers with mutations in the BRAF or RAS genes.
(University of Texas M. D. Anderson Cancer Center) The University of Texas MD Anderson Cancer Center was awarded $22.3 million from the Cancer Prevention and Research Institute of Texas (CPRIT), accounting for 30 percent of the $73.5 million in awards CPRIT announced today.
(University of Texas M. D. Anderson Cancer Center) Three simultaneous safety and efficacy studies of the drug larotrectinib reported an overall response rate of 75 percent for patients ages four months to 76 years with 17 different cancer diagnoses. Show More Summary
(Johns Hopkins Medicine) In what is believed to be the largest pancreatic cancer genome-wide association study to date, researchers at the Johns Hopkins Kimmel Cancer Center and the National Cancer Institute, and collaborators from over 80 other institutions worldwide discovered changes to five new regions in the human genome that may increase the risk of pancreatic cancer.
Celebs Attend ‘Couture Against Cancer’ Fundraiser Celebs took a break from hitting the Staples Center to join BBWLA star Angel Brinks and a slew of others for a good cause over All Star weekend. The Couture Against Cancer charity fundraiser
(German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)) Enhancing the diagnosis of breast cancer is the stated goal of a research team at the German Cancer Research Center (DKFZ) in Heidelberg. The scientists have combined...Show More Summary
(Biophysical Society) Cell division is an intricately choreographed ballet of proteins and molecules that divide the cell. During mitosis, microtubule-organizing centers assemble the spindle fibers that separate the copying chromosomes of DNA. Show More Summary
(Ohio State University Wexner Medical Center) A clinically relevant 'liquid biopsy' test can be used to profile cancer genomes from blood and predict survival outcomes for patients with metastatic triple negative breast cancer (TNBC),...Show More Summary
(Ohio State University Wexner Medical Center) Many breast cancer patients undergoing mastectomy with or without immediate reconstruction mispredict future satisfaction with aspects of physical and sexual health post-surgery, according to a new study published by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. Show More Summary
Researchers from Arizona State University and National Center for Nanoscience and Technology of the Chinese Academy of Sciences have developed a remarkable new way of killing tumors. They’ve developed robot-like nanoscale devices that cling to the walls of tumor vessels, release a clotting agent, and block the tumor from receiving nutrients. These nanorobots, which consist […]
(Medical University of South Carolina) Clinical researcher, Alana Rojewski, Ph.D., receives career development award to study smoking cessation programs in an oncology setting at MUSC Hollings Cancer Center and benefits of technology-based interventions for lung cancer screening patients.
(NIH/National Cancer Institute) The 2018 Szent-Györgyi Prize for Progress in Cancer Research will be awarded to Douglas R. Lowy, M.D., and John T. Schiller, Ph.D., of the Center for Cancer Research at the National Cancer Institute (NCI), one of the National Institutes of Health (NIH). Show More Summary
In a major advancement in nanomedicine, Arizona State University (ASU) scientists, in collaboration with researchers from the National Center for Nanoscience and Technology (NCNST), of the Chinese Academy of Sciences, have successfully programmed nanorobots to shrink tumors by cutting off their blood supply.
UT Southwestern Medical Center is one of nine exclusive sites in the country enrolling multiple myeloma patients for a clinical trial of the CAR-T "living drug" therapy for cancer.
A kinase inhibitor called cabozantinib could be a viable therapy option for patients with metastatic, radioactive iodine-resistant thyroid cancer. In a trial initiated and led by the Abramson Cancer Center and the Perelman School ofShow More Summary
(University of Texas M. D. Anderson Cancer Center) Obese patients with metastatic melanoma who are treated with targeted or immune therapies live significantly longer than those with a normal body mass index (BMI), investigators report...Show More Summary
(University of Texas M. D. Anderson Cancer Center) A common cold virus engineered to attack the most common and deadly of brain tumors allowed 20 percent of patients with recurrent glioblastoma to live for three years or longer, researchers from The University of Texas MD Anderson Cancer Center report on a phase I clinical trial in the Journal of Clinical Oncology.
(Georgetown University Medical Center) Family history of breast cancer continues to significantly increase chances of developing invasive breast tumors in aging women -- those ages 65 and older. The findings of a new study could impact mammography screening decisions later in life.
(Georgetown University Medical Center) Combining an anti-angiogenesis agent, which blocks blood vessel formation, with an immunotherapy agent, was found to have promising anti-tumor activity and no unexpected side effects in an early-phase clinical trial in patients with advanced kidney cancer.